(PFE) Pfizer Stock Price Forecast: 2024 and Beyond
In the ever-evolving pharmaceutical landscape, Pfizer (NYSE: PFE) is a key player, with its stock forecast garnering significant interest from investors and analysts alike. Heading into 2024 and beyond, the consensus tilts towards a cautiously optimistic outlook for Pfizer's stock. This optimism is underpinned by the company's strong product lineup, including vital pharmaceuticals and promising new treatments and vaccines. While analysts offer varied price targets, they anticipate potential grow
Read more »